|
|
|
| Abbot Laboratories: ABT-510, ABT-751, A-176120, ABT-510 |
| Abgenix, Inc.: Panitumumab |
| Abraxis BioScience: Abraxane |
| Adherex Technologies Inc.: ADH-1 |
| Amgen: Conatumumab, Motesanib, Vectibix |
| antioChem: GRN1005 |
| ANTISENSE PHARMA GmbH: AP 12009 |
| Antisoma plc: AS1411 |
| Ardea Biosciences, Inc.: RDEA119 |
| ARIAD Pharmaceuticals, Inc.: Ridaforolimus |
| Arqule, Inc.: ARQ 197 |
| Array BioPharma: Selumetinib |
| Astex Therapeutics: AT13387 |
| AstraZeneca: ZD9331, AZD8055, Arimidex, Faslodex, Iressa, ZD6474, ZD9331, Zoladex |
| Aton Pharma, Inc.: Zolinza |
| Auckland Cancer Society Research Centre: PR104 |
| AVEO Pharmaceuticals, Inc.: SCH-900105 |
| Æterna Zentaris Inc.: Perifosine, Neovastat |
| Bayer Corporation: Sorafenib |
| Bedford Laboratories: Cladribine |
| Berlex Laboratories: Fludarabine, Campath |
| Biogen, Inc.: BIIB022 |
| BiPar Sciences Inc: BSI-201 |
| Boehringer Ingelheim Pharma KG: BIBX 1382 |
| Bristol-Myers-Squibb: BMS-214662, Cetuximab, BMS-214662, Cytoxan, Ixempra, Sprycel |
| BTG International Ltd: Abiraterone |
| Calistoga Pharmaceuticals, Inc.: CAL-101 |
| CanBas Co., Ltd.: CBP501 |
| Celator Pharmaceuticals, Inc: CPX-1 |
| Celgene Corporation: Amrubicin, RevLimid, Vidaza |
| Cell Therapeutics, Inc.: XYOTAX |
| CELLDEX THERAPEUTICS, INC.: PF-4948568 |
| Centocor Ortho Biotech, Inc.: Doxil |
| Daiichi Pharmaceutical Co., Ltd.: DJ-927 |
| Eisai, Inc.: E7070, Eribulin |
| Eli Lilly and Company: ISIS 3521, Alimta, Gemzar |
| EMD Biosciences, Inc.
: Entinostat |
| EntreMed, Inc.: Panzem |
| Epeius Biotechnologies: Rexin-G |
| Exelixis, Inc.: XL184 |
| F. Hoffmann-La Roche Ltd: Erlotinib, Xeloda |
| Fresenius AG: Rexomun |
| Fujisawa Pharmaceutical Co., Ltd.: romidepsin |
| Genentech Inc.: Erlotinib, Avastin, Herceptin, Rituxan |
| Genmab, Inc.: HuMax-EGFr |
| Gensia Sicor Pharmaceuticals, Inc.: Cytarabine |
| Genta, Inc.: Genasense |
| Genzyme: Clofarabine |
| Geron Corporation: GRN163 |
| GlaxoSmithKline: GSK1120212, Navelbine, Votrient |
| ImClone Systems Incorporated: Cixutumumab, Cetuximab, Erbitux |
| Immunogen Inc.: MLN2704 |
| Incyte Corporation: INC280 |
| Indena SpA: BAY 59-8862 |
| Infinity Pharmaceuticals: IPI-926 |
| Insititue of Cancer Research, Sutton, UK: ICR62 |
| ISIS Pharmaceuticals: Affinitak, ISIS 3521 |
| Janssen: Zarnestra |
| Johnson & Johnson: Abiraterone, Yondelis |
| Keryx Biopharmaceuticals, Inc.: Perifosine |
| KuDOS Pharmaceuticals, Ltd.: Olaparib |
| Ligand Pharmaceuticals: Targretin |
| Lpath, Inc.: Sonepcizumab |
| Matrix Pharmaceuticals, Inc.: Cisplatin-epinephrine gel |
| Medarex: Ipilimumab |
| MediGene AG: EndoTAG(TM)-1 |
| MedImmune, Inc.: Siplizumab |
| Merck & Co., Inc.: Dalotuzumab |
| Merck KGaA: Cetuximab |
| Merrimack Pharmaceuticals Inc.: MM-111 |
| MethylGene Inc: MGCD0103 |
| Millenium Pharmaceuticals, Inc.: MLN2704, Bortezomib, Velcade |
| MolMed: NGR-hTNF |
| Neopharm: LE-SN38 |
| Nereus Pharmaceuticals: NPI-0052 |
| Nerviano Medical Sciences: PHA-848125 |
| Novartis: Midostaurin, AEE788, Afinitor, Femara, Gleevec, Imatinib |
| Oncolytics Biotech, Inc.: Reolysin |
| Oncotest GmbH: Omnitarg |
| Onyx Pharmaceuticals: Nexavar, ONYX-015 |
| OSI Pharmaceuticals, Inc.: CP-724,714, Tarceva |
| Oxigene, Inc: Combretastatin A4P |
| Pfizer Inc.: CI-1033, PF-4948568, AG2037, CI-1033, Sutent, Viracept |
| Pharmacia & Upjohn Comp: Aromasin |
| Pharmacia Corporation: Camptosar |
| PharmaMar USA
: Trabectedin |
| Piramed Ltd: GDC-0941 |
| Plexxicon, Inc.: vemurafenib |
| Prolx Pharmaceuticals Corp.: PX-866 |
| Regeneron Pharmaceuticals: Aflibercept |
| Roche Pharmaceuticals: RO4929097 |
| Sanofi-Aventis: Oblimersen sodium, Taxotere |
| Sanofi-Synthelabo: Tirapazamine, Eloxatin |
| Schering AG: PTK787 |
| Schering-Plough: robatumumab, Sarasar, Temodar® |
| Seattle Genetics, Inc.: SGN-30, Brentuximab Vedotin |
| Sumitomo Pharmaceutical Co., Ltd.: Calsed |
| SuperGen, Inc.: Decitabine, Orathecin |
| Synta Pharmaceuticals Corp.: STA-4783 |
| Taiho Pharmaceutical Co. Ltd: S-1 |
| Takeda Pharmaceutical Companies Ltd: TAK-960 |
| Thallion Pharmaceuticals Inc.: TLN-4601 |
| Threshold Pharmaceuticals: TH-302 |
| TopoTarget A/s: Belinostat |
| Tracon Pharma: TRC093 |
| valeant pharmaceuticals: FLUOROURACIL |
| Vion Pharmaceuticals, INC.: Triapine |
| Wyeth-Ayerst Research: Torisel, Neratinib, Rapamune |
| YM BioSciences Inc.: Nimotuzumab |
| Zeltia Group: Trabectedin |
| ZERIA Pharmaceuticals: Z-360 |
| |
| |
|
|
